ARBEKACIN SULPHATE
- CAS NO.:104931-87-5
- Empirical Formula: C22H46N6O14S
- Molecular Weight: 650.7
- MDL number: MFCD00896451
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-15 10:44:02
What is ARBEKACIN SULPHATE?
The Uses of ARBEKACIN SULPHATE
Arbekacin Sulfate (Technical Grade) is used as an anti methicillin-resistant Staphylococcus aureus drugs.
Definition
ChEBI: Arbekacin sulfate is an aminoglycoside sulfate salt. It is functionally related to an arbekacin.
Properties of ARBEKACIN SULPHATE
| solubility | Water (Slightly) |
| form | Solid |
| color | White |
Safety information for ARBEKACIN SULPHATE
Computed Descriptors for ARBEKACIN SULPHATE
New Products
Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-MethylpyridineRelated products of tetrahydrofuran








You may like
-
17471-10-2 Diphenhydramine EP impurity-A /Diphenhydramine Related Compound A NLT 95%View Details
17471-10-2 -
Dorzolamide Related Compound B/Dorzolamide EP Impurity B NLT 95%View Details
120279-90-5 -
76824-16-3 Famotidine - Impurity D NLT 95%View Details
76824-16-3 -
Metoprolol Impurity T NLT 95%View Details
73723-85-0 -
118-23-0 NLT 95%View Details
118-23-0 -
Miconazole EP Impurity F/ Miconazole USP Related Compound F 47447-55-2 NLT 95%View Details
47447-55-2 -
2407630-84-4 NLT 95%View Details
2407630-84-4 -
573704-41-3 NLT 95%View Details
573704-41-3
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
